Lymphocytic Lymphoma, Moxetumomab Pasudotox
1 clinical trials · Condition
◉ Watch Lymphocytic Lymphoma, Moxetumomab Pasudotox
| Record | Firm | Date |
|---|---|---|
| A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia (NCT00587457) | MedImmune LLC | 2007-03-07 |
Track Lymphocytic Lymphoma, Moxetumomab Pasudotox automatically
Every clearance here is in the API, with alerts when new ones post.